80 related articles for article (PubMed ID: 1883359)
1. Purification of large neuromedin N (NMN) from canine intestine and its identification as NMN-125.
Carraway RE; Mitra SP
Biochem Biophys Res Commun; 1991 Aug; 179(1):301-8. PubMed ID: 1883359
[TBL] [Abstract][Full Text] [Related]
2. Differential processing of neurotensin/neuromedin N precursor(s) in canine brain and intestine.
Carraway RE; Mitra SP
J Biol Chem; 1990 May; 265(15):8627-31. PubMed ID: 2341398
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of neurotensin/neuromedin N mRNA and products of NT/NMN precursor processing in neonatal rats.
Muraki K; Mitra SP; Dobner PR; Carraway RE
Peptides; 1993; 14(6):1095-102. PubMed ID: 8134290
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific processing of neurotensin/neuromedin-N precursor in cat.
Carraway RE; Mitra SP; Joyce TJ
Regul Pept; 1993 Jan; 43(1-2):97-106. PubMed ID: 8426913
[TBL] [Abstract][Full Text] [Related]
5. BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing.
Carraway RE; Mitra SP; Evers BM; Townsend CM
Regul Pept; 1994 Aug; 53(1):17-29. PubMed ID: 7800856
[TBL] [Abstract][Full Text] [Related]
6. Canine neurotensin, neurotensin6-13 and neuromedin N: primary structures and receptor activity.
Mitra SP; Muraki K; Brown DR; Parsons AM; Carraway RE
Regul Pept; 1990 Mar; 28(1):11-22. PubMed ID: 2158127
[TBL] [Abstract][Full Text] [Related]
7. Presence of neurotensin and neuromedin-N within a common precursor from a human pancreatic neuroendocrine tumor.
Carraway RE; Mitra SP; Feurle GE; Hacki WH
J Clin Endocrinol Metab; 1988 Jun; 66(6):1323-8. PubMed ID: 3131383
[TBL] [Abstract][Full Text] [Related]
8. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
[TBL] [Abstract][Full Text] [Related]
9. Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation.
Ernst A; Hellmich S; Bergmann A
Peptides; 2006 Jul; 27(7):1787-93. PubMed ID: 16519961
[TBL] [Abstract][Full Text] [Related]
10. Cloning and sequence analysis of cDNA for the canine neurotensin/neuromedin N precursor.
Dobner PR; Barber DL; Villa-Komaroff L; McKiernan C
Proc Natl Acad Sci U S A; 1987 May; 84(10):3516-20. PubMed ID: 3472221
[TBL] [Abstract][Full Text] [Related]
11. Characterization of large neuromedin-N using antisera towards regions of the neurotensin/neuromedin-N precursor.
Carraway RE; Mitra SP; Paradise C
Peptides; 1991; 12(3):601-7. PubMed ID: 1923937
[TBL] [Abstract][Full Text] [Related]
12. Isolation and quantitation of several new peptides from the canine neurotensin/neuromedin N precursor.
Carraway RE; Mitra SP; Salmonsen R
Peptides; 1992; 13(6):1039-47. PubMed ID: 1494486
[TBL] [Abstract][Full Text] [Related]
13. The use of radioimmunoassay to compare the tissue and subcellular distributions of neurotensin and neuromedin N in the cat.
Carraway RE; Mitra SP
Endocrinology; 1987 May; 120(5):2092-100. PubMed ID: 3569126
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier transport kinetics of the neuromedin peptides NMU, NMN, NMB and NT.
Gevaert B; Wynendaele E; Stalmans S; Bracke N; D'Hondt M; Smolders I; van Eeckhaut A; De Spiegeleer B
Neuropharmacology; 2016 Aug; 107():460-470. PubMed ID: 27040796
[TBL] [Abstract][Full Text] [Related]
15. Precursor forms of neurotensin (NT) in cat: processing with pepsin yields NT-(3-13) and NT-(4-13).
Carraway RE; Mitra SP
Regul Pept; 1987 Aug; 18(3-4):139-54. PubMed ID: 3118422
[TBL] [Abstract][Full Text] [Related]
16. Potential precursors to neuromedin N in the cat and their processing by pepsin.
Carraway RE; Mitra SP
Endocrinology; 1987 May; 120(5):2101-7. PubMed ID: 3106014
[TBL] [Abstract][Full Text] [Related]
17. Purification and partial amino acid sequence of fuctinin, an endogenous inhibitor of fucosyltransferase activities.
Ruggiero-Lopez D; Manioc C; Geourjon C; Louisot P; Martin A
Eur J Biochem; 1994 Aug; 224(1):47-55. PubMed ID: 8076650
[TBL] [Abstract][Full Text] [Related]
18. Purification and partial characterization of canine S100A12.
Heilmann RM; Suchodolski JS; Steiner JM
Biochimie; 2010 Dec; 92(12):1914-22. PubMed ID: 20727380
[TBL] [Abstract][Full Text] [Related]
19. Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosa.
Barelli H; Mao YK; Vincent B; Daniel EE; Vincent JP; Checler F
Peptides; 1993; 14(3):457-63. PubMed ID: 8332546
[TBL] [Abstract][Full Text] [Related]
20. Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients.
Christ-Crain M; Stoeckli R; Ernst A; Morgenthaler NG; Bilz S; Korbonits M; Struck J; Bergmann A; Müller B; Keller U
J Clin Endocrinol Metab; 2006 Sep; 91(9):3544-7. PubMed ID: 16787986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
